STERIS (NYSE:STE) Updates FY 2025 Earnings Guidance

STERIS (NYSE:STE) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 9.050-9.150 for the period, compared to the consensus earnings per share estimate of 9.060. The company issued revenue guidance of $5.4 billion-$5.4 billion, compared to the consensus revenue estimate of $5.5 billion.

Wall Street Analyst Weigh In

STE has been the topic of several recent analyst reports. Stephens reaffirmed an “overweight” rating and set a $260.00 target price on shares of STERIS in a research note on Thursday, November 7th. JMP Securities reissued a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research note on Monday, November 18th. Piper Sandler upped their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday. StockNews.com cut STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, November 8th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus target price of $263.75.

STERIS Trading Up 0.7 %

Shares of STE stock traded up $1.57 during trading hours on Wednesday, reaching $220.97. The company had a trading volume of 887,926 shares, compared to its average volume of 476,648. STERIS has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a 50 day moving average of $212.33 and a 200 day moving average of $224.59. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55. The firm has a market cap of $21.81 billion, a price-to-earnings ratio of 50.45 and a beta of 0.84.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.02% and a return on equity of 13.78%. On average, equities research analysts anticipate that STERIS will post 9.11 EPS for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.03%. STERIS’s payout ratio is 52.05%.

Insider Activity at STERIS

In other news, SVP Cary L. Majors sold 1,682 shares of the stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the transaction, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,471,363.04. This represents a 12.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.14% of the stock is owned by company insiders.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.